Related Experiment Video
Updated: Feb 13, 2026

Detection of Functional Matrix Metalloproteinases by Zymography
Published on: November 8, 2010
Glucocorticoids induce apoptosis and matrix metalloproteinase-13 expression in chondrocytes through the NOX4/ROS/p38
Ying Huang1, Gui-Quan Cai2, Jian-Ping Peng2
1Department of Anesthesiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 200092, Shanghai, China.
Abstract:
Based on the results from our previous study, dexamethasone (Dex) increases reactive oxygen species (ROS) levels and subsequently induces cell death and matrix catabolism in chondrocytes. Nevertheless, the mechanism underlying this phenomenon remains unclear. Nicotinamide adenine dinucleotide (phosphate) (NADPH) oxidase 4 (NOX4) is one of the major enzymes responsible for intracellular ROS production during the inflammatory process. The objective of the current study was to investigate the role of NOX4 in Dex-induced ROS over-production. Healthy chondrocytes were harvested from the cartilage debris from 6 female patients. NOX4 and p38 mitogen-activated protein kinase (MAPK) expression levels in these cells were evaluated in the presence of Dex. Changes in the number of apoptotic and viable Dex-treated chondrocytes were recorded after the cells were treated with NOX and p38 MAPK inhibitors. Changes in matrix metalloproteinase 13 (MMP-13) expression levels in Dex-treated chondrocytes were also investigated. The Dex treatment increased NOX4 expression via the glucocorticoid receptor (GR). Treatment of cells with apocynin, a NOX inhibitor, decreased intracellular ROS levels and inhibited p38 MAPK activation. Treatment of cells with a ROS scavenger also reduced p38 MAPK expression. Treatment of cells with a NOX inhibitor, ROS scavenger and p38 MAPK inhibitor rescued chondrocytes from Dex-induced apoptosis. Moreover, treatment of cells with these agents blocked MMP-13 expression in Dex-treated chondrocytes. NOX4 silencing also suppressed p38 MAPK and MMP-13 expression. Dex triggered apoptosis and MMP-13 expression through the NOX4/ROS/p38 MAPK signaling pathway. NOX4 may be a therapeutic target in the management of Dex-induced complications.
Insights
Dexamethasone (Dex) increases cell death by raising reactive oxygen species (ROS) via NOX4. Inhibiting NOX4, ROS, or p38 MAPK protects chondrocytes from Dex-induced apoptosis and matrix breakdown.
Area of Science:
- Cell Biology
- Biochemistry
- Pharmacology
Background:
- Dexamethasone (Dex) is known to induce chondrocyte apoptosis and matrix catabolism.
- The precise mechanism by which Dex increases reactive oxygen species (ROS) and causes these effects remains unclear.
- Nicotinamide adenine dinucleotide (phosphate) (NADPH) oxidase 4 (NOX4) is a key enzyme in ROS production during inflammation.
Purpose of the Study:
- To investigate the role of NOX4 in dexamethasone-induced ROS overproduction in chondrocytes.
- To elucidate the signaling pathway involved in Dex-induced chondrocyte apoptosis and matrix metalloproteinase 13 (MMP-13) expression.
Main Methods:
- Healthy human chondrocytes were treated with Dex.
- NOX4 and p38 mitogen-activated protein kinase (MAPK) expression levels were assessed.
- Chondrocytes were treated with NOX inhibitors (apocynin), ROS scavengers, and p38 MAPK inhibitors.
- Apoptosis, cell viability, and MMP-13 expression were evaluated.
- NOX4 was silenced using specific techniques.
Main Results:
- Dex treatment increased NOX4 expression through the glucocorticoid receptor (GR).
- NOX inhibition and ROS scavenging reduced intracellular ROS and p38 MAPK activation.
- Inhibiting NOX4, ROS, or p38 MAPK protected chondrocytes from Dex-induced apoptosis.
- These treatments also blocked MMP-13 expression, and NOX4 silencing similarly reduced MMP-13 and p38 MAPK levels.
Conclusions:
- Dexamethasone triggers chondrocyte apoptosis and MMP-13 expression via the NOX4/ROS/p38 MAPK signaling pathway.
- NOX4 is identified as a potential therapeutic target for mitigating Dex-induced chondrocyte damage.
More Related Videos
Related Concept Videos
MAPK Signaling Cascades
Apoptosis
The Extracellular Matrix
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Carbon-13 (¹³C) NMR: Overview

